Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moshe Mittelman

Showing results (51-60 of 114) with videos related to

Pageof 12
Sort By:
Medical Education|October 1, 2008
MOR: a simulation-based assessment centre for evaluating the personal and interpersonal qualities of medical school candidatesAmitai Ziv, Orit Rubin, Avital Moshinsky, et al.
Leukemia & Lymphoma|January 4, 2018
Is bone marrow examination always necessary to establish the diagnosis of myelodysplastic syndromes? A proposed non-invasive diagnostic modelHoward S Oster, Gal Carmi, Alex Kolomansky, et al.
British Journal of Haematology|August 29, 2025
Next-generation morphology, a novel multilayer morphometric digital analysis, reveals both the basic topology and new trends of myelodysplasia of peripheral blood specimensBen-Zion Katz, Yakir Moshe, Dan Bensity, et al.
Hematological Oncology|July 8, 2020
Kinetics of pre-myelodysplastic syndromes blood values correlate with disease risk and survivalErel Joffe, Uri Greenbaum, Gili Man-El, et al.
British Journal of Haematology|June 17, 2025
Can we identify individuals at risk to develop multiple myeloma? A machine learning-based predictive modelMoshe Mittelman, Ariel Israel, Howard S Oster, et al.
The Israel Medical Association Journal : IMAJ|January 12, 2007
Adherence to guidelines for patients hospitalized with heart failure: a nationwide surveyAlan B Jotkowitz, Avi Porath, Avraham Shotan, et al.
Acta Haematologica|December 17, 2023
The Effect of Oral Iron Chelator Deferiprone on Iron Overload and Oxidative Stress in Patients with Myelodysplastic Syndromes: A Study by the Israeli MDS Working GroupDrorit Merkel, Shelly Soffer, Kalman Filanovsky, et al.
American Journal of Hematology|June 17, 2024
Roxadustat versus placebo for patients with lower-risk myelodysplastic syndrome: MATTERHORN phase 3, double-blind, randomized controlled trialMoshe Mittelman, David H Henry, John A Glaspy, et al.
Cardiovascular Toxicology|April 1, 2003
A chemically induced rat model of hemolysis with disseminated thrombosisNathan Ezov, Tal Levin-Harrus, Moshe Mittelman, et al.
Thrombosis Journal|September 18, 2014
The influence of Erythropoietin on platelet activation, thrombin generation and FVII/active FVII in patients with AMIGabriele Demetz, Magdalena Laux, Armin Scherhag, et al.
Pageof 12

Showing results (51-60 of 114) with videos related to

Sort By:
Pageof 12
Medical Education|October 1, 2008
MOR: a simulation-based assessment centre for evaluating the personal and interpersonal qualities of medical school candidatesAmitai Ziv, Orit Rubin, Avital Moshinsky, et al.
Leukemia & Lymphoma|January 4, 2018
Is bone marrow examination always necessary to establish the diagnosis of myelodysplastic syndromes? A proposed non-invasive diagnostic modelHoward S Oster, Gal Carmi, Alex Kolomansky, et al.
British Journal of Haematology|August 29, 2025
Next-generation morphology, a novel multilayer morphometric digital analysis, reveals both the basic topology and new trends of myelodysplasia of peripheral blood specimensBen-Zion Katz, Yakir Moshe, Dan Bensity, et al.
Hematological Oncology|July 8, 2020
Kinetics of pre-myelodysplastic syndromes blood values correlate with disease risk and survivalErel Joffe, Uri Greenbaum, Gili Man-El, et al.
British Journal of Haematology|June 17, 2025
Can we identify individuals at risk to develop multiple myeloma? A machine learning-based predictive modelMoshe Mittelman, Ariel Israel, Howard S Oster, et al.
The Israel Medical Association Journal : IMAJ|January 12, 2007
Adherence to guidelines for patients hospitalized with heart failure: a nationwide surveyAlan B Jotkowitz, Avi Porath, Avraham Shotan, et al.
Acta Haematologica|December 17, 2023
The Effect of Oral Iron Chelator Deferiprone on Iron Overload and Oxidative Stress in Patients with Myelodysplastic Syndromes: A Study by the Israeli MDS Working GroupDrorit Merkel, Shelly Soffer, Kalman Filanovsky, et al.
American Journal of Hematology|June 17, 2024
Roxadustat versus placebo for patients with lower-risk myelodysplastic syndrome: MATTERHORN phase 3, double-blind, randomized controlled trialMoshe Mittelman, David H Henry, John A Glaspy, et al.
Cardiovascular Toxicology|April 1, 2003
A chemically induced rat model of hemolysis with disseminated thrombosisNathan Ezov, Tal Levin-Harrus, Moshe Mittelman, et al.
Thrombosis Journal|September 18, 2014
The influence of Erythropoietin on platelet activation, thrombin generation and FVII/active FVII in patients with AMIGabriele Demetz, Magdalena Laux, Armin Scherhag, et al.
Pageof 12